About Vivimed Labs
Vivimed Labs is a company based in Hyderabad (India) founded in 1988. The company has 59 employees as of April 05, 2025. Vivimed Labs has completed 2 acquisitions, including Klar Sehen Private Limited and UQUIFA Group. Vivimed Labs offers products and services including Active Pharmaceutical Ingredients and Finished Dosage Formulations. Vivimed Labs operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter Hyderabad, India
- Employees 59 as on 05 Apr, 2025
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vivimed Labs Limited
-
Annual Revenue
$13.58 M (USD)-22as on Mar 31, 2025
-
Net Profit
-$3.74 M (USD)29.67as on Mar 31, 2025
-
EBITDA
-$1.52 M (USD)41.18as on Mar 31, 2025
-
Latest Funding Round
$7.5 M (USD), Post-IPO
Jan 01, 2018
-
Investors
International Finance Corporation
& 3 more
-
Employee Count
59
as on Apr 05, 2025
-
Investments & Acquisitions
Klar Sehen Private Limited
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Vivimed Labs
Vivimed Labs is a publicly listed company on the BSE with ticker symbol VIVIMEDLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Vivimed Labs
Vivimed Labs offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients and Finished Dosage Formulations.
Production of key chemical components for drugs and healthcare products.
Development of ready-to-use pharmaceutical products for global markets.
People of Vivimed Labs
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Vivimed Labs
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $7.5M
-
First Round
First Round
(28 Sep 2011)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Post-IPO - Vivimed Labs | Valuation |
investors |
|
| Sep, 2017 | Amount | Post-IPO - Vivimed Labs | Valuation |
investors |
|
| Aug, 2014 | Amount | Post-IPO - Vivimed Labs | Valuation |
investors |
Investors in Vivimed Labs
Vivimed Labs has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include International Finance Corporation, Orbimed and Kitara Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Investment management and co-investment services through global networks.
|
Founded Year | Domain | Location | |
|
IFC is focused on private sector development in emerging markets.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vivimed Labs
Vivimed Labs has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Klar Sehen Private Limited and UQUIFA Group.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Commercial catering and kitchen equipment are supplied nationwide.
|
1977 | ||||
|
CDMO company manufacturing APIs and intermediates
|
1936 |
Financial Statements - Vivimed Labs
Vivimed Labs Comparisons
Competitors of Vivimed Labs
Vivimed Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| domain | founded_year | HQ Location |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
Contract research and development services for small molecules are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
Frequently Asked Questions about Vivimed Labs
Vivimed Labs was founded in 1988 and raised its 1st funding round 23 years after it was founded.
Vivimed Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Santosh Varalwar is the current CEO of Vivimed Labs.
As of Apr 05, 2025, the latest employee count at Vivimed Labs is 59.
Annual revenue of Vivimed Labs is $13.58M as on Mar 31, 2025.
Vivimed Labs is a global supplier of speciality chemicals and pharmaceuticals and a manufacturer of active pharmaceutical ingredients, formulations and active ingredients for Home and Personal Care, hair dyes, imaging chemicals and photochromics. Vivimed Labs has a customer base spread across 50 countries. The company is engaged in the manufacture of Cosmetics, Pharmaceuticals, Nutraceuticals, Photochromics, Natural Actives, Colors and Dyes. Since 2005, Vivimed has expanded rapidly with the acquisition of companies like James Robinson, UK, and Har-Met International Inc. The company currently has 5 manufacturing plants located in India along with RD labs in the UK and India.
Vivimed Labs's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Vivimed Labs offers Active Pharmaceutical Ingredients and Finished Dosage Formulations.
Yes, Vivimed Labs is publicly traded on BSE under the ticker symbol VIVIMEDLAB.
Vivimed Labs has made 2 acquisitions, including Klar Sehen Private Limited, and UQUIFA Group.
Vivimed Labs has 4 investors. Key investors include International Finance Corporation, Orbimed, Kitara Capital, and Nylim-jb Asset Management.
The ticker symbol of Vivimed Labs is VIVIMEDLAB on BSE.